Neumann Mark
- SEC CIK
- 0001756211
No open-market purchases or sales filed in the past year.
Current role at each company
- MANE Veradermics, IncChief Commercial Officeras of Feb 5, 2026
- ITCI Intra-Cellular Therapies, Inc.EVP, Chief Commercial Officeras of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Neumann Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ITCI Intra-Cellular Therapies, Inc.
EVP, Chief Commercial Officer16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 (view filing) | Aug 16 | 4 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −18.7K | $75.08 | −$1.41M | −38.7%29.7K after | |
| Mar 11, 2024 (view filing) | Mar 7-11 | 4 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −20.5K | $66.23 | −$1.36M | −40.8%29.7K after | 5 lots10b5-1 |
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −7.91K | $70.13 | −$554.5K | −21.0%29.7K after | 4 lots10b5-1 |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −11.9K | $67.15 | −$796.4K | −28.5%29.7K after | 2 lots10b5-1 |
| Nov 8, 2023 (view filing) | Nov 6 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −42.4K | $55.63 | −$2.36M | −58.8%29.7K after | 2 lots |
| Aug 9, 2023 (view filing) | Aug 7 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −55.3K | $58.79 | −$3.25M | −54.9%45.3K after | |
| Mar 30, 2023 (view filing) | Mar 28 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −15.6K | $54.31 | −$847.4K | −25.6%45.3K after | 2 lots10b5-1 |
| Mar 13, 2023 (view filing) | Mar 10-13 | 3 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −12.3K | $43.84 | −$539.6K | −16.8%60.9K after | 4 lots |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −7.24K | $50.01 | −$362.1K | −12.8%49.2K after | |
| Feb 27, 2023 (view filing) | Feb 24 | 3 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −4.05K | $47.12 | −$190.6K | −6.7%56.4K after |